In the NewsApril 11, 2024Top Medical Testing Startups For Personalised Health InsightsApril 9, 2024Should You Worry About Rising Mpox Cases?March 4, 2024Fierce Medtech's Fierce 15 of 2023February 5, 2024Cell-Free DNA May Inform IBD DiagnosisJanuary 9, 2024100 BEST PLACES TO WORK IN THE U.S. 2024December 6, 2023Brad Perkins, MD: New Data on Test Which Helped Identify Pneumonia-Causing PathogensLoad morePress ReleasesOctober 10, 2023Karius Test® Improves the Diagnosis and Management of Pneumonia in Patients Undergoing Treatment for Blood CancerAugust 10, 2023Karius Inc. Adds Dr. Norman Sharpless, Former National Cancer Institute Head, and Elizabeth O’Farrell, Eli Lilly Veteran, to its Board of DirectorsAugust 2, 2023Karius Test®, a Liquid Biopsy for Infectious Diseases, Incorporated into Diagnostics Recommendation in the 2023 Duke-ISCVID Criteria for Infective EndocarditisApril 11, 2023Karius and eGenesis Partner to Help Accelerate Xenotransplantation for Patients in Need of Organ TransplantsJune 9, 2022Karius® Partners with Capstone Health Alliance to Widen Patient Access to Liquid Biopsy Test for Infectious DiseasesDecember 9, 2021Karius Prepares for Further Growth with New Chief Financial Officer, Chief Legal Officer Appointments